Erlotinib
targeted anticancer therapy · kinase inhibitor
Nothing to addWhat this medicine is for
Erlotinib belongs to the "anticancer targeted therapy (kinase inhibitor)" category. This targeted therapy attacks a specific mechanism of tumor cells; it falls under specialized hospital prescription.
Specifically, for Erlotinib: Treats a cancer by targeting tumor cells. It is part of specialized, closely monitored care.
Under which brands it is found
Erlotinib is part of the composition of about 6 presentations listed in France. It comes under various trade names and in generic form.
- Erlotinib Biogaran
- Erlotinib Eg
- Erlotinib Sandoz
- Erlotinib Teva France
- Erlotinib Viatris
- Erlotinib Zentiva
Original brand-name products and generics deliver the same active substance; the choice between them is made with your doctor or pharmacist.
Do you need a supplement? No.
We put forward no supplement for Erlotinib: that would be forcing a need that does not exist. The great majority of medicines call for no particular supplementation, and acknowledging this is part of the way we work. We design a supplement only where the data support it, across five specific classes.
Talk about it in the community
Members are already discussing the topic: sensations, doubts, everyday tips. People speak frankly here, without lecturing or prescribing.
Related molecules
To explore in the « Other areas » family and its neighbours.